Morphic Therapeutic
Company Details
Status: Public
Employees: 101-250
Location:
Waltham, Massachusetts, United States
Type:
sample
Technology:
sample
sample
sample
sample
About: Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases.
Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn's disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention.
Despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Morphic Therapeutic | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.